
3i cancels sale of £182m ACR stake
3i has cancelled the £182m sale of its stake in Singapore-headquartered reinsurance company Asian Capital Re (ACR) to Asia Investment Capital.
According to trade publication Asian Insurance Review, the decision was a mutual one and was a result of "additional approvals required by Chinese regulators", which would have delayed the deal into 2018.
The development comes 13 months after 3i announced it had agreed to sell the company to the company jointly controlled by Shenzhen-government-sponsored investment firms Shenzhen Qianhai Financial Holdings and Shenzhen Investment Holdings.
The deal would have valued ACR at around $1bn. The GP said in a statement that its stake in the business had a book value of £131m as of June 2017, while the original deal valued the stake at a 42% premium on its £128m book value in June 2016.
ACR provides reinsurance and specialises in large and complex risks across non-life business lines. It has additional operations in Hong Kong, Dubai, Taiwan, Japan, Korea, Vietnam and India.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater